REQUEST A DEMO
Total
USD $0.00
Search more companies

Global Pharma Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Global Pharma Sp. z o.o. Profile Updated: October 07, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Global Pharma Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The enterprise was incorporated on August 27, 2008. It currently has a total number of 5 (2009) employees. Its’ total assets recorded a growth of 7689.58%.

Headquarters
Ul. Grzybowska 87
Warsaw; Mazowieckie; Postal Code: 00-844

Contact Details: Purchase the Global Pharma Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Global Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Global Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Global Pharma Sp. z o.o. report to view the information.
Incorporation Date:
August 27, 2008
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Global Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
7689.58%
Total equity
7429.43%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?